CSIMarket



Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Capital Expenditures Growth by Quarter and Year

Pfizer Inc's Capital Expenditures results by quarter and year




PFE Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - 993.00 1,286.00 726.00
III Quarter October - 624.00 530.00 662.00
II Quarter July - 540.00 480.00 588.00
I Quarter April 643.00 554.00 495.00 618.00
FY   643.00 2,711.00 2,791.00 2,594.00



PFE Capital Expenditures first quarter 2022 Y/Y Growth Comment
Pfizer Inc achieved in the first quarter 2022, above Company average Capital Expenditures increase of 16.06% year on year, to $ 643.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 71 other companies have achieved higher Capital Expenditures growth. While Pfizer Inc' s Capital Expenditures growth of 16.06% ranks overall at the positon no. 1464 in the first quarter 2022.




PFE Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - -22.78 % 77.13 % -8.33 %
III Quarter October - 17.74 % -19.94 % 17.79 %
II Quarter July - 12.5 % -18.37 % 28.95 %
I Quarter April 16.06 % 11.92 % -19.9 % 60.1 %
FY   - -2.87 % 7.59 % 18.12 %

Financial Statements
Pfizer Inc's first quarter 2022 Capital Expenditures $ 643.00 millions PFE's Income Statement
Pfizer Inc's first quarter 2021 Capital Expenditures $ 554.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Capital Expenditures Growth >>


PFE Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - 59.13 % 142.64 % 9.67 %
III Quarter October - 15.56 % 10.42 % 12.59 %
II Quarter July - -2.53 % -3.03 % -4.85 %
I Quarter April -35.25 % -56.92 % -31.82 % -21.97 %
FY (Year on Year)   - -2.87 % 7.59 % 18.12 %




Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #72
Healthcare Sector #268
Overall #1464

Capital Expenditures Y/Y Growth Statistics
High Average Low
35.39 % 3.15 % -11.32 %
(Dec 31 2018)   (Sep 30 2018)
Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #72
Healthcare Sector #268
Overall #1464
Capital Expenditures Y/Y Growth Statistics
High Average Low
35.39 % 3.15 % -11.32 %
(Dec 31 2018)   (Sep 30 2018)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Pfizer Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
143.2 % 18 % -100 %
(June 30. 2011)  


PFE's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Pfizer Inc reported fall in Capital Expenditures sequentially by -35.25% to $ 643.00 millions, from $ 993.00 millions achived in the previous reporting period.

If you look into recent shortcoming at the I. Quarter, you should take into consideration, that commonly I. Quarter Capital Expenditures appear to be sluggish in contrast to the quarter before, Madison Campbell, Major Pharmaceutical Preparations industry veteran said.

Within Major Pharmaceutical Preparations industry 144 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pfizer Inc's Capital Expenditures growth quarter on quarter, overall rank is 2442.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #145
Healthcare Sector #442
Overall #2442
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #145
Healthcare Sector #442
Overall #2442
Capital Expenditures Q/Q Growth Statistics
High Average Low
143.2 % 18 % -100 %
(June 30. 2011)  


PFE's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Pfizer Inc realized fall in Capital Expenditures from the previous quarter by -35.25% to $ 643.00 millions, from $ 993.00 millions released in the previous reporting period.

This is not important issue, as I. Quarter Capital Expenditures frequently gravitate to slow in the I. Quarter.

Within Major Pharmaceutical Preparations industry 144 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pfizer Inc's Capital Expenditures growth quarter on quarter, overall rank is 2442.


Pfizer Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Oct 03 2021)
12 Months Ending
(Jul 04 2021)
12 Months Ending
(Apr 04 2021)
Cumulative Capital Expenditures 12 Months Ending $ 2,800.00 $ 2,711.00 $ 3,004.00 $ 2,910.00 $ 2,850.00
Y / Y Capital Expenditures Growth (TTM) -1.75 % -2.87 % 34.65 % 23.15 % 15.34 %
Year on Year Capital Expenditures Growth Overall Ranking # 1676 # 2224 # 868 # 732 # 877
Seqeuential Capital Expenditures Change (TTM) 3.28 % -9.75 % 3.23 % 2.11 % 2.11 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1747 # 2505 # 1792 # 1750 # 1666




Cumulative Capital Expenditures growth Comment
Pfizer Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2021. If the fiscal year would end in Apr 03 2022, Pfizer Inc's annual Capital Expenditures improvement would be -1.75% year on year to $2,800 millions.

In the Healthcare sector 289 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 1676, from total ranking in previous quarter at 2224.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
35.39 %
3.15 %
-11.32 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 290
Overall # 1676

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
64 %
13.8 %
-18.86 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 78
Sector # 301
S&P 500 # 1747
Cumulative Capital Expenditures growth Comment
Pfizer Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2021. If the fiscal year would end in Apr 03 2022, Pfizer Inc's annual Capital Expenditures fall would be -1.75% year on year to $2,800 millions.

In the Healthcare sector 289 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 1676, from total ranking in previous quarter at 2224.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
35.39 %
3.15 %
-11.32 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 290
Overall # 1676

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
64 %
13.8 %
-18.86 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 78
Sector # 301
S&P 500 # 1747




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PFE's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PFE's Competitors
Capital Expenditures Growth for Pfizer Inc's Suppliers
Capital Expenditures Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Apr 03 2022
Staar Surgical Co17.60%$ 17.601 millions
Pfizer Inc16.06%$ 16.065 millions
Nutriband Inc.12.96%$ 12.955 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CYOU's Profile

Stock Price

CYOU's Financials

Business Description

Fundamentals

Charts & Quotes

CYOU's News

Suppliers

CYOU's Competitors

Customers & Markets

Economic Indicators

CYOU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071